Type 2 diabetes patients set for major shake-up in care
The health service should move from a one-size-fits-all approach of starting everyone on the same medication, to more personalised care that aims to prevent complications like heart failure and heart attacks, according to new draft guidance from the National Institute for Health and Care Excellence (Nice).
This includes making newer type 2 diabetes drugs, known as SGLT-2 inhibitors, a first-line treatment option in a move that could eventually help save tens of thousands of lives.
SGLT-2 inhibitors, which include canagliflozin, dapagliflozin, empagliflozin, and ertugliflozin, are once-a-day tablets that reduce blood sugar levels by helping the kidneys remove glucose, which is passed from the body through urine.
However, analysis by Nice found these drugs are under-prescribed.
The new guidelines recommend patients who cannot tolerate metformin – the first-choice in type 2 diabetes medication – should start with an SGLT-2 inhibitor on its own.
The decision comes after evidence suggested these drugs protect the heart and kidneys as well as controlling blood sugar, Nice said.
It is estimated the change could save almost 22,000 lives once uptake reaches 90% of the population.
Nice also suggests some groups of patients would also benefit from GLP-1 receptor agonists such as liraglutide or semaglutide sooner, rather than keeping them for the later stages of treatment.
Semaglutide, sold under the brand name Ozempic, is licensed in the UK to treat type 2 diabetes, while its other brand – Wegovy – is also used by the NHS to help obese people lose weight.
Professor Jonathan Benger, deputy chief executive and chief medical officer at Nice, said: 'This guidance means more people will be offered medicines where it is right to do so to reduce their future risk of ill health.
'This represents a significant evolution in how we approach type 2 diabetes treatment.
'We're moving beyond simply managing blood sugar to taking a holistic view of a person's health, particularly their cardiovascular and kidney health.
'The evidence shows that certain medicines can provide important cardiovascular benefits, and by recommending them as part of initial treatment, we could help prevent heart attacks, strokes and other serious complications before they occur.
'This is particularly important given that cardiovascular disease is the leading cause of death in people with type 2 diabetes.'
Around 4.6 million people in the UK are living with diabetes, with nine in 10 of those having type 2.
However, it is estimated that a further 1.3 million people may have undiagnosed type 2 diabetes.
Nice analysed the records of 590,000 people and found SGLT-2 inhibitors are under-prescribed, particularly to women, older people, and black patients.
Prof Benger added: 'The evidence from our analysis is clear. There are prescribing gaps that need to be addressed.
'The guideline update published today will help to increase equitable uptake of SGLT-2 inhibitors, which we know can prevent serious health complications.'
Dr Waqaar Shah, chairman of the guideline committee, added: 'We know that SGLT-2 inhibitors are currently under-prescribed, and our health economics analysis shows that people living in the most deprived areas would particularly benefit from universal access to these treatments.
'These recommendations could help reduce health inequalities while providing better outcomes for everyone.'
Elsewhere, the draft guidance suggests different treatments for diabetes patients with certain characteristics or health conditions.
These include adults with cardiovascular disease, who should be offered a triple therapy including a GLP-1 receptor agonist.
Meanwhile, adults diagnosed with type 2 diabetes before 40 should be offered dual therapy before a GLP-1 receptor agonist is considered, while patients with chronic kidney disease should have tailored recommendations based on their kidney function.
A public consultation on the new Nice guidelines is open until October 2.
Douglas Twenefour, head of clinical at Diabetes UK, said: 'This long-awaited announcement propels type 2 diabetes treatment into the 21st century.
'Boosting access to newer treatments will be transformative for people with type 2 diabetes, while ensuring the UK keeps pace with the global momentum in treating the condition.
'The majority of people with type 2 diabetes are not currently taking the most effective medication for them, putting them at risk of devastating diabetes-related complications.
'Diabetes is a leading cause of cardiovascular disease, and tailoring treatment based on individual risk could protect thousands against heart attacks and kidney disease.
'These guidelines could go a long way to easing the burden of living with this relentless condition, as well as helping to address inequities in type 2 diabetes treatments and outcomes.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
BBC News
19 minutes ago
- BBC News
Northampton hospital to build new urgent treatment centre
A hospital that requires improvement has announced it hopes to build a new urgent treatment centre and emergency department entrance for General Hospital (NGH) said the new facility would "create a central hub for all urgent and emergency care services" and could open in a year's time. A Care Quality Commission (CQC) report, released last week, found patients had waited on chairs for more than 22 Churchward, the hospital chief executive, said its "old estate" presented lots of challenges. The new building would replace the existing Springfield Urgent Treatment Centre, which opened in 2017, and also replace the Portakabin entrances which have been in situ as a temporary measure since 2023."We've known for several years that our urgent and emergency care pathways at NGH have needed longer term improvement," added Ms Churchward. "Bringing our urgent and emergency care facilities under one roof will improve the experience patients have when they need urgent or lifesaving care."The hospital said if it gets planning approval, there would be changes to the road layout on the was downgraded from good, to requires improvement, following the surprise inspection in February. Follow Northamptonshire news on BBC Sounds, Facebook, Instagram and X.
BBC News
19 minutes ago
- BBC News
RSPB Sandwell Valley bird watching group helps those with dementia
A birdwatching group is helping people with dementia and their loved ones to find therapy in the great group, set up through a unique collaboration between the RSPB and Age UK, runs weekly at the RSPB Sandwell Valley reserve in Great Barr, Tidman, from Age UK Sandwell & Birmingham, set up the group after growing up immersed in nature, thanks to his father Jeff's own love of 83, was diagnosed with frontal lobe vascular Alzheimer's around five years ago, so his son knew the benefits the group could bring to people with dementia. "My dad has always been interested in birds and he would teach me and everyone I know about them," Steve Tidman, who lives with his father in Pelsall, said."So that love of birds has rubbed off on me."Despite the Alzheimer's, Steve says his father always remembers a lot of birds."He can see a bird in the sky and instantly recognise it," he set up the group, which runs at the RSPB's reserve every Tuesday from 12:00 until 14:00 BST. It has now been running successfully for several months, with the number of people regularly attending going up and up."It's just gone from strength to strength," Steve said."It's therapeutic, it's socially interactive, it helps with memory stimulation. It's something to look forward to each week."It's getting people out in nature and loving nature again. They can go back to their own gardens and potentially feed their own birds and find that interest in nature." 'Love being in the open' He added that those with dementia who attend a number of sessions "are recognising bird song and recognising bird species they potentially wouldn't have seen before".Jeff also attends the sessions with his son and loves spotting the different types of birds across the RSPB reserve."I love being out in the open," Jeff said. "Especially when I had my dog, I'd be up and down the canal, in the fields - anywhere I could, as long as I was away from people." David Footitt, who has been a volunteer at RSPB Sandwell Valley since 2023, helps to run the wife and mother both had dementia before they died, so David is also passionate about the group and the benefits it can bring."This group in particular we've seen grow from a group of quite reticent shy individuals, coming in unsure of what's going on, and are now quite eager to attend the meetings and they are really enthusiastic with what they see," he said. Carers benefit too Both David and Steve have seen how people attending the group week after week are learning the different types of birds and remembering them when they spot them again."They will say, 'Oh, there's a coot, that's a great crested grebe', and just weeks ago they were completely unaware," David is also brilliant to see is the impact on the carers and loved ones attending the group, David said."I think for the carers in particular and the relatives who come along it's been such a support for them," he said. "There's a social interaction that's gone way past our expectations." Several members of the group spoke to the BBC about what they enjoyed about Harris, aged 76 from Great Barr, said: "It's very interesting seeing the birds because [for] a long time I haven't been able o go out."I really enjoyed it and everyone has been so courteous and nice." 'We didn't know many birds' Pauline Francis, aged 73 from Perry Barr, attends with her husband who has dementia."I'm waiting until I can actually have him in this surrounding," she said."I do enjoy coming and I want to continue coming to keep the group going and to encourage other people, to spread the word."Lynda Grout also attends after husband Edward developed dementia. "We used to go walking a lot. We can't walk as far anymore, so it was just a chance to get back to nature really," she said."We've learned the names of birds, we didn't know many before." Age UK functions as many independent branches, and Steve hopes Age UK Sandwell & Birmingham's collaboration with the RSPB can be replicated in other areas of the Sandwell Valley birdwatching group currently has funding until December 2026, with Age UK looking to raise funds to continue the project further. Follow BBC Birmingham on BBC Sounds, Facebook, X and Instagram.
The Guardian
19 minutes ago
- The Guardian
Young people want to ‘go private' – I'm a lifelong supporter of the NHS, but I can see why
It is 10.25am on a Friday and I am Googling 'online pharmacies'. I have a mild infection and I weigh up whether talking to an AI doctor will be more efficient than queueing at my GP surgery before the weekend. After a seven-minute multiple-choice questionnaire, I am deemed eligible for antibiotics: a single sachet is £43. I close the page and consider spending the cash self-medicating with a family-size Uber Eats instead. I thought of this later as I read the news that half of millennials in the UK are planning to use private healthcare in the next year. A survey by the Independent Healthcare Provider Network found that those aged 34 to 44 were the most likely age group to go private. Forty-nine per cent said they were likely to use it in the next 12 months, with young professionals increasingly opting for employment with medical insurance. Forget career progression or annual leave, nowadays jobseekers want eye tests and cancer checks. As a millennial with the long-term health conditions of a boomer, I can identify with this mindset. I've always been ideologically against private healthcare, to the extent that when that Bupa advert comes on the TV where the woman in remission from cancer dances joyfully, I involuntarily yell: 'Parasites! Did she have to sell her home to pay for chemotherapy?!' But with NHS waiting lists still sky high, like many, I've found myself relying on private healthcare for the first time. When I had nerve damage in my arm and was struggling to type this column, I reluctantly booked an appointment with a private physiotherapist rather than waiting several months on the NHS. Without private insurance, I paid the £75 an hour cost and felt lucky that I could afford to. This is clearly a problem for the individual: a generation who entered the workforce during a global recession and has to pay astronomical costs for house deposits and childcare is now expected to find cash for healthcare too. But it is also a problem for the rest of society: a 40-year-old who will probably pay taxes for the next 25 years but already doesn't feel as if they get enough from the NHS will be less invested in the service in the future, and at worst, resentful in light of intergenerational inequality and an ageing population they will need to support. The government knows it. In a speech this summer, the health secretary, Wes Streeting, warned that younger people 'opting out' of the NHS and going private 'presents an existential risk to the health service'. 'The NHS feels increasingly slow and outdated to the generation that organises their lives at the touch of a button,' he said. 'If you get annoyed at Deliveroo not getting your dinner to you in less than an hour, how will you feel being told to wait a year for a knee operation?' There is some truth to Streeting's statement: a demographic that is tech savvy and can organise their social and professional lives on demand feel particularly put off by a healthcare system in which they have to call a landline at 8am to book an appointment or wait for the post to tell them about a scan in nine months. When I went private for physio, I was struck by the flexibility and patient-led focus: while the NHS often struggles to provide an appointment at a time that's accessible to my chronic fatigue (and is openly baffled by the request), the private clinic was happy to do it in two halves to fit with my energy levels. But it is disingenuous – and a distraction – to suggest that the shift to private provision is about a craving for choice or even quicker care, as if millennials are Carrie Bradshaw shopping around for high-end healthcare. In the survey by the Independent Healthcare Provider Network, nearly half of respondents cited difficulties getting an NHS appointment at all as the main reason for using private healthcare. One in 10 said they did so because their NHS appointment was outright cancelled or postponed. For many, going private isn't about wanting a choice – it's a reflection of the fact a creaking NHS means they increasingly don't have one. When we talk about the encroachment of private companies on the universal healthcare model, we tend to hear about the logistics: the NHS now outsources nearly £3.5bn of procedures to private hospitals to help speed up waiting lists, despite most doctors who do the private surgeries being siphoned off from the NHS. And yet the issue is also our political culture – one that nudges the public ever closer to accepting private healthcare as a necessity rather than a luxury. Whether it is Nigel Farage floating the idea of a mix of private and public healthcare or Tony Blair advocating for 'an expanded role' for private firms, the strategy is clear enough: starve the NHS of resources, and drive down the quality and availability of the service, and patients will get used to looking elsewhere. That younger people increasingly treat employer health insurance as a requirement rather than a perk shows how effective this cultural shift has been: a US-style connection between work and health means medical care can be viewed bit by bit not as a right for all, but a privilege for the LinkedIn few. We have already seen this with dentistry, with it becoming the norm in recent years for patients to be left without an NHS dentist even for critical care. The end result is a lesson in what happens when universal coverage disappears: private dentists have hiked up their prices, while record numbers of people are turning to dental insurance and those without cover pull out their own teeth. In the end, I braved the GP's surgery. The process was reassuring in its mundanity: a short wait on the phone, a 10-minute call, then a prescription bought with a pre-payment certificate at no extra cost. If it wasn't too on the nose, I would suggest every doctor's surgery in the country changes its hold music to Big Yellow Taxi by Joni Mitchell. 'Don't it always seem to go / That you don't know what you've got till it's gone …' Frances Ryan is a Guardian columnist. She is the author of Who Wants Normal? The Disabled Girls' Guide to Life
